Company / Current Assets
AIM ImmunoTech Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$3.3M
FY2025
5-year range
$3.3M / $50.2M
FY2021-FY2025
Trend
-21.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $50M in FY2021 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -39.4%.
Declined from $15M to $3M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -55.1%
- 5-Year CAGR
- -39.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- AIM ImmunoTech Inc.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of -39.4%, indicating a declining trend.
- In FY2025, current assets decreased 21.1% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.3M | -21.1% |
| FY2024 | $4.2M | -71.3% |
| FY2023 | $14.6M | -59.9% |
| FY2022 | $36.3M | -27.7% |
| FY2021 | $50.2M | +24.6% |
| FY2020 | $40.3M | +285.9% |
| FY2019 | $10.4M | +175.0% |
| FY2018 | $3.8M | +8.4% |
| FY2017 | $3.5M | -49.5% |
| FY2016 | $6.9M | -34.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026